Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Clinical Studies
  • View Item
  • Home
  • ICR Divisions
  • Clinical Studies
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM study

Thumbnail
View/Open
Supporting information (63.31Kb)
Publication Date
2017-05
ICR Author
Larkin, James
Marsden,
Author
Dreno, B
Ribas, A
Larkin, J
Ascierto, PA
Hauschild, A
Thomas, L
Grob, J-J
Koralek, DO
Rooney, I
Hsu, JJ
McKenna, EF
McArthur, GA
Type
Journal Article
Metadata
Show full item record
URL
https://repository.icr.ac.uk/handle/internal/1473
Collections
  • Clinical Studies
Version of record
10.1093/annonc/mdx040
Subject
cobimetinib
MEK inhibition
melanoma
safety
Research team
Melanoma and Kidney Cancer
License start date
2017-05
Citation
ANNALS OF ONCOLOGY, 2017, 28 (5), pp. 1137 - 1144

Browse

All of ICR repositoryICR Divisions & RM Clinical UnitsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.